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Background: Localized fibrous tumors of the pleura (LFTPs) are rare neoplasms, which are
considered to originate from submesothelial connective tissue. The aim of this article is
to present 15 new cases because of their different clinical behaviors and to discuss the
treatment of choice of such neoplasms.
Methods: The records of 15 consecutive patients with LFTP operated at our Institution
between 1995 and 2006 were retrospectively reviewed. Diagnostic procedures, clinical
courses, and outcomes of these patients were studied. Total excision through a thoracot-
omy was performed in all patients. Neoplasms were considered to be malignant if one or
more of the following histologic features were present: increasing mitotic activity; high
cellularity with crowding and overlapping of nuclei; necrosis; and pleomorphism.
Results: No operative mortality was reported. The mean follow-up time was 76 months.
Malignant transformation was seen in 1 patient 26 months after resection of a benign
tumor. Six cases were pathologically considered to be malignant: 2 patients developed local
recurrence. One of these underwent redo-surgery and required pneumonectomy; in the
other one surgery is not indicated because at the time of diagnosis the patient was 85 years.
Currently, all patients are alive and 13 disease-free.
Conclusions: For histologically benign tumors, because of the risk of recurrence and malig-
nant transformation, complete surgical resection is indicated and long-term follow-up is
recommended in all patients. For malignant cases, complete surgical resection may be
insufficient for the cure: further study should be performed to identify reliable prognostic
factors to indicate and evaluate the effectiveness of systemic treatment.
ª 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction characteristic (negative for cytokeratin expression and positiveLocalized fibrous tumors of the pleura (LFTPs) are rare, slow-
growing neoplasms with about 900 cases reported in the
literature to date.1 LFTPs can usually be distinguished from
malignant mesothelioma by their radiographic features,
gross appearance (often pedunculated), immunohistologicPerna).
al Associates Ltd. Publishfor CD34), and ultrastructural characteristic. Thirteen percent
of reported tumors had aggressive clinical behavior with local
infiltration and local recurrence or distant metastasis. The
remaining 87% had benign clinical behavior and were resected
completely, including adjacent structures if necessary, which
is generally believed to be sufficient treatment.2 The aim ofed by Elsevier Ltd. All rights reserved.
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because of their different clinical behaviors and to discuss the
treatment of choice of such neoplasms.2. Material and methods
The records of 15 consecutive patients with LFTPs (3 men, 12
women) operated at our Institution between 1995 and 2006
were retrospectively reviewed. The mean age was 51.5 years
(range, 29–82 years). We reexamined pathologic slides, and
malignant LFTP was diagnosed when one of following criteria
was satisfied3: increasing mitotic activity (>4 mitoses per 10
high-power fields); high cellularity with crowding and over-
lapping of nuclei; presence of necrosis; and mild, moderate,
or marked pleomorphism. To differentiate the cell origin of
resected tumors, we performed immunostaining for a panel
of cell markers including vimentin, CD34, cytokeratin, and
S-100.4,5 History taking, a physical examination, a routine
blood test, standard chest radiography, electrocardiography,
and a thoracic computed tomographic (CT) scan were avail-
able for all patients. Fiberoptic bronchoscopy was performed
in 12 patients. In all of them, extrinsic compression of seg-
mental bronchi was observed, but no endobronchial lesion
was detected. CT guided aspiration biopsy was performed in
9 patients: in 4 patients, histologic examination revealedFig. 1 – Chest roentgenogram (top left). Computed tomogram rev
and bottom left). Gross morphologic image of the mass (bottombenign appearing spindle cells and this suggested diagnosis
of benign pleural fibrous tumor; in 1 patient the specimen sug-
gested sclerosing hemangioma of the lung; in 4 patients spec-
imens were not significant. Chest pain (in 2 patients), dyspnea
(in 3 patients), cough (in 1 patient), and hemoptysis (in 2
patients) were the symptoms. Eight patients were symptom-
free. No patient had asbestos exposure. Two patients showed
associated disease: breast carcinoma and endometrial squa-
mous cell carcinoma. Operative mortality was defined as
deathwithin 30 days of an operation or during hospitalization.
Recent patient status was determined by using the clinical
records of outpatient clinics or by telephone interview.3. Results
Surgical excision was performed by posterolateral thoracot-
omy in all patients. There was no operative morbidity or mor-
tality. The largest mass excised in our patients was
23 20 18 cm and 3000 g (Fig. 1). Four of the cases were
based on the visceral pleura and 11 arose from the parietal
pleura. Three tumors were pedunculated on visceral pleura-
based pedicles. Among tumors arising from the visceral
pleura, one showed a prevalent intrapulmonary growth (the
so-called inverted fibroma). For tumors related to the visceral
pleura, the resection was performed by wedge resection. Oneealing a broad-based mass on the parietal pleura (top right
right).




Mean age 63.5 50.3
Visceral pleura
origin and pedunculated morphology
2 1
Parietal pleura
origin and sessile morphology
4 7
Presence of symptoms 1 6
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sion of the tumor (inverted fibroma). Tumors arising from the
parietal pleura, even if not invading the chest wall, obliged the
surgeon to be more accurate during resection particularly in
the control of possible bleeding related to the extrapleural
dissection. Chest-wall resectionwas required in 2 cases. Com-
plete tumor resection as evidenced by pathologic examina-
tions was obtained in all cases. There were 9 pathologically
benign LFTP cases, and 6 malignant LFTP cases. Details about
malignity criteria are reported in Table 1. All tumors stained
positively for CD34 and vimentin but negatively for keratin,
and S-100. No adjuvant therapy was used. The mean follow-
up time for benign LFTP was 73.2 months and that for
malignant was 78.6 months. Among malignant LFTP cases, 2
developed local recurrence. One of these underwent redo-
surgery and required pneumonectomy; in the other one
surgery is not indicated because at the time of diagnosis the
patient was 85 years. Malignant transformation was seen in
1 patient 26 months after resection of a benign tumor. Rethor-
acotomy revealed multiple pleural and lung metastasis. The
patient received postoperative radiotherapy and is currently
alive (follow-up 19 months).4. Comment
LFTPs are uncommon, representing less than 5% of all neo-
plasms involving the pleura.6 LFTPs show no gender predilec-
tion.7 In our series, therewas amarked female predilection (12
female and 3 male) and, according to the literature, no cases
were observed in childhood.
The usual presentation is an asymptomatic mass discov-
ered incidentally on a chest radiograph.8 Symptoms, if any,
tend to be more common in larger lesions withmalignant his-
tological features and include either local symptoms, such as
chest pain, cough, dyspnea, and more rarely hemoptysis (in
our series, 2 cases), or systemic symptoms, such as weakness,
nocturnal sweating, chills, weight loss, digital clubbing,
hypertrophic osteoarthropathy, and hypoglycemia.9 In our
series, there was no correlation between symptoms and the
presence of malignancy (Table 2). When symptoms are pres-
ent regressing completely after surgical resection,10 as
observed in our patients.
CT guided aspiration biopsy is not a reliable diagnostic
tool11; in fact, only 4 of 9 cases (45%) were identified by CT
guided aspiration biopsy. Surgical resection for diagnosis
and treatment is acceptable if the patient is operable, because
operative morbidity and mortality are very small.
The great majority of LFTPs have a benign clinical outcome
with a long-term disease-free survival in around 90% of theTable 1 – Malignity criteria among the 6 malignant
tumors
Criterion of malignity No. of tumors
Increasing mitotic activity 4
High cellularity 2
Presence of necrosis 4
Pleomorphism 3cases. The single best predictor of a benign course was the
complete excision with microscopically free surgical mar-
gins.12 Intraoperative examination of the surgical margins is
therefore mandatory. Approximately 10% of the benign LFTPs
recur with malignant change rarely supervening (<0.5%).2 In
our series, malignant transformation was seen in 1 patient
26 months after resection of a benign tumor. Probably it was
the first case in the literature with multiple pleural and lung
metastases and it was impossible to perform a complete
resection.
In our study, 4 out of the 11 tumors with an origin from the
parietal pleura and a sessile morphology hadmalignant histo-
logical features; in the sameway, 2 out of the 4 tumors with an
origin from the visceral pleura and a pedunculated morphol-
ogy had malignant histological features (Table 2). Among ma-
lignant LFTP cases, developed local recurrence a tumor with
an origin from the parietal pleura and a sessile morphology
and a tumor with an origin from the visceral pleura and a pe-
dunculated morphology: our data partially confirm the find-
ings of other authors1,12 of a more aggressive behavior of
LFTP with an origin from the parietal pleura and a sessile
morphology.
Tumor size has been reported as being a prognostic
factor,13 since larger LFTPs tend to havemalignant histological
features and a worse prognosis. In our study, 4 out of the 9
tumors with benign histological features and 4 out of the 6
tumors with malignant histological features were over 10 cm
in diameter; we also classified a 23 cm tumor as benign, which
indicates that large size is not necessarily a marker of
malignancy.
We observed the expression of CD34 and vimentin in all
tumors, which confirm the role of thesemarkers in diagnosing
LFTP.14
Surgical treatment is associated with favorable results,
with 10-year survival rates varying from 75%14 to 94%.3We ob-
served a 5-year survival rate of 100% and a 5-year disease-free
survival rate of 80%, which is in accordance with previous
reports.3,12,14
The role of adjuvant treatments for LFTP has been only par-
tially investigated, although radio and chemotherapy have
shown to be effective in treating selected patients.15 For ma-
lignant cases, complete surgical resection may be insufficient
for the cure: preoperative or postoperative systemic therapy
should be considered in selected patients who have the
highest risk of recurrence.
However, as observed in part in our series, currently there
are no reliable prognostic factors that allow selecting this type
of patients.
i n t e rn a t i o n a l j o u rn a l o f s u r g e r y 6 ( 2 0 0 8 ) 2 9 8 – 3 0 1 301In conclusion, although LFTPs are considered histologically
benign tumors, because of the risk of recurrence and malig-
nant transformation, complete surgical resection is indicated
and long-term follow-up is recommended in all patients. Fur-
ther studies are required to identify reliable prognostic factors
andmulticenter trials to evaluate the effectiveness of preoper-
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